Nantahala Capital Management’s Cartesian Therapeutics RNAC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-74,474	Closed	-$1.54M	–	129
2023 Q4	$1.54M	Buy	74,474 +1,141	+2%	+$23.6K	0.09%	81
2023 Q3	$2.33M	Buy	73,333 +40,000	+120%	+$1.27M	0.2%	72
2023 Q2	$1.12M	Hold	33,333	–	–	0.11%	76
2023 Q1	$1.39M	Buy	+33,333	New	+$1.39M	0.11%	76